CIZUMAB 300MG INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: HETERO HEALTHCARE LTD (ONCOLOGY DIV)

MRP: ₹8508.00

HETERO HEALTHCARE LTD (ONCOLOGY DIV): Cizumab 300MG Injection, 1 vial, salt bevacizumab 300mg. NPPA has revised its MRP from Rs 17,900 to Rs 8,508 (52% lower) with effect from 09-11-2026; trade rate Rs 6,482.29. Group: anti-VEGF monoclonal antibody (targeted therapy). Same salt is also supplied by Reliance Life Sciences. Handling/counselling: infusion only in a hospital or day-care set-up; hold around surgery; store at 2-8 C, do not freeze. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.